Insider Trading & Ownership - Foley Mark J

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Foley Mark J
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-03-06
Purchase
2024-03-08
4:33 pm
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
30,000$6.98$209,4001,126,381
(Indirect
Direct)
View
2024-02-23
Sale
2024-02-26
7:01 pm
GLAUKOS CorpGKOSFoley Mark J
Director
4,560$92.87$423,48733,220
(Direct)
View
2023-08-03
Sale
2023-08-04
5:07 pm
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
26,279$22.57$593,151951,288
(Indirect
Direct)
View
2023-07-03
Sale
2023-07-05
9:11 pm
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
26,279$24.94$655,333977,567
(Indirect
Direct)
View
2023-06-09
Sale
2023-06-13
8:09 pm
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
31,279$30.72$960,9281,002,846
(Indirect
Direct)
View
2023-05-15
Sale
2023-05-16
8:29 pm
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
70,447$34.55$2,433,7251,034,125
(Indirect
Direct)
View
2023-03-09
Sale
2023-03-09
9:45 pm
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
70,390$31.59$2,223,360934,264
(Indirect
Direct)
View
2021-11-29
Purchase
2021-11-29
9:24 pm
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
40,000$12.9$515,924879,978
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-29
Option Award
2024-03-04
4:33 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
70,750$01,096,381
(Direct)
View
2024-02-23
Exercise
2024-02-26
7:01 pm
N/A
2024-07-10
GLAUKOS CorpGKOSFoley Mark J
Director
10,000$033,220
(Direct)
View
2024-02-23
Exercise
2024-02-26
7:01 pm
N/A
N/A
GLAUKOS CorpGKOSFoley Mark J
Director
10,000$7.27533,220
(Direct)
View
2024-01-31
Option Award
2024-02-02
4:45 pm
2025-02-15
2028-01-31
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
1,070,001$01,070,001
(Direct)
View
2023-12-31
Option Award
2024-01-03
4:47 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
264$7.471,025,631
(Direct)
View
2023-08-11
Option Award
2023-08-15
4:15 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
122,143$01,025,367
(Direct)
View
2023-08-11
Tax Withholding
2023-08-15
4:15 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
48,064$18.911,025,367
(Direct)
View
2023-06-30
Option Award
2023-07-05
9:11 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
1,000$15.61977,567
(Direct)
View
2023-06-01
Option Award
2023-06-05
8:14 pm
N/A
N/A
GLAUKOS CorpGKOSFoley Mark J
Director
3,230$027,780
(Direct)
View
2022-02-02
Option Award
2023-05-16
8:29 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
175,649$01,034,125
(Direct)
View
2023-03-15
Tax Withholding
2023-03-17
3:22 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
5,341$30.65928,923
(Direct)
View
2022-09-22
Option Award
2023-03-09
9:45 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
175,649$0934,264
(Direct)
View
2023-01-03
Option Award
2023-01-04
5:58 pm
N/A
N/A
GLAUKOS CorpGKOSFoley Mark J
Director
2,948$024,550
(Direct)
View
2022-12-31
Option Award
2023-01-03
4:28 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
605$12.18829,005
(Direct)
View
2022-10-13
Tax Withholding
2022-10-14
7:02 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
49,274$26.97828,400
(Direct)
View
2022-06-30
Option Award
2022-07-05
6:15 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
1,000$11.75877,674
(Direct)
View
2022-06-02
Option Award
2022-06-06
7:55 pm
N/A
N/A
GLAUKOS CorpGKOSFoley Mark J
Director
4,364$021,602
(Direct)
View
2022-03-15
Tax Withholding
2022-03-17
5:54 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
Chief Executive Officer
3,304$15.79876,674
(Direct)
View
2022-02-02
Option Award
2022-02-04
8:35 pm
N/A
2032-02-01
Revance Therapeutics Inc.RVNCFoley Mark J
CEO
143,354$0143,354
(Direct)
View
2022-01-03
Option Award
2022-01-05
8:55 pm
N/A
N/A
GLAUKOS CorpGKOSFoley Mark J
Director
2,486$017,238
(Direct)
View
2021-10-13
Tax Withholding
2021-10-15
8:00 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO & President
42,096$23.08839,978
(Direct)
View
2021-06-30
Other
2021-07-02
7:52 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO & President
882$24.09882,956
(Direct)
View
2021-06-03
Option Award
2021-06-07
7:04 pm
N/A
N/A
GLAUKOS CorpGKOSFoley Mark J
Director
2,382$014,752
(Direct)
View
2021-02-02
Option Award
2021-02-04
9:10 pm
N/A
2031-02-01
Revance Therapeutics Inc.RVNCFoley Mark J
CEO & President
114,380$0954,857
(Direct)
View
2021-01-04
Option Award
2021-01-06
9:30 pm
N/A
N/A
GLAUKOS CorpGKOSFoley Mark J
Director
1,184$012,370
(Direct)
View
2020-07-23
Option Award
2020-10-15
6:57 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO & President
315,352$0840,477
(Direct)
View
2020-10-13
Tax Withholding
2020-10-15
6:57 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO & President
66,106$27.62840,477
(Direct)
View
2020-09-30
Option Award
2020-10-02
8:33 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO & President
301,000$0591,231
(Direct)
View
2020-09-30
Tax Withholding
2020-10-02
8:33 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO & President
143,269$25.14591,231
(Direct)
View
2020-06-16
Option Award
2020-06-18
7:10 pm
N/A
N/A
SI-BONE Inc.SIBNFoley Mark J
Director
8,797$08,797
(Direct)
View
2020-06-03
Option Award
2020-06-05
9:51 pm
N/A
N/A
GLAUKOS CorpGKOSFoley Mark J
Director
3,900$011,186
(Direct)
View
2020-01-23
Option Award
2020-01-24
8:22 pm
N/A
N/A
Revance Therapeutics Inc.RVNCFoley Mark J
CEO & President
200,000$0413,500
(Direct)
View
2019-10-13
Option Award
2019-10-15
8:23 pm
N/A
2029-10-12
Revance Therapeutics Inc.RVNCFoley Mark J
CEO & President
940,000$0973,500
(Direct)
View
2019-06-13
Option Award
2019-06-17
7:41 pm
N/A
2029-06-12
SI-BONE Inc.SIBNFoley Mark J
Director
26,236$026,236
(Direct)
View

Ownership
2019-06-17
7:40 pm
N/A
N/A
SI-BONE Inc.SIBNFoley Mark J
Director
0$00
(Direct)
View
2019-05-30
Option Award
2019-05-31
8:06 pm
N/A
N/A
GLAUKOS CorpGKOSFoley Mark J
Director
2,653$07,286
(Direct)
View
2019-05-09
Option Award
2019-05-10
8:52 pm
N/A
2029-05-08
Revance Therapeutics Inc.RVNCFoley Mark J
Director
13,500$051,500
(Direct)
View